Last $13.49 USD
Change Today -0.38 / -2.74%
Volume 144.0K
FLML On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 5:20 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Catherine Bréchignac Ph.D.

Chairman of Scientific Advisory Board, Director and Member of Nominating & Corporate Governance Committee, Flamel Technologies SA
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 4 different industries.

See Board Relationships
67--

Background*

Ms. Catherine Bréchignac served as the Chairman of the Board and Director of Research at National Center for Scientific Research (CNRS). Ms. Bréchignac served as the President of CNRS from 2006 to 2010 and served as its Director General from 1997 to 2000. She serves as the Chairwoman of Board of Directors of Palais de la Découverte. She has been a Director of Flamel Technologies SA since June 24, 2011. She serves on the Board of Ecole des Mines de Paris and Flamel Technologies ...

Read Full Background

Corporate Headquarters*

Parc Club du Moulin à Vent
Vénissieux, Rhône-Alpes 69693

France

Phone: 33 472 78 34 34
Fax: 33 472 78 34 35

Board Members Memberships*

Former Independent Director
2006-N/A
Former Director and Member of International Strategy Committee
2011-Present
Chairman of Scientific Advisory Board, Director and Member of Nominating & Corporate Governance Committee

Education*

PhD
Ecole Normale Superieure

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FLML:US $13.49 USD -0.38

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
$500.0K
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
Onxeo SA
€276.9K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FLAMEL TECHNOLOGIES-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.